Status:
UNKNOWN
α-Mangostin Hydrogel Film With Chitosan Alginate Base for Recurrent Aphthous Stomatitis (RAS)
Lead Sponsor:
Universitas Padjadjaran
Conditions:
Recurrent Aphthous Stomatitis
Eligibility:
All Genders
18-59 years
Phase:
PHASE2
Brief Summary
Recurrent Aphthous Stomatitis (RAS) is experienced by almost everyone and appears suddenly. Even though the risk of death due to the condition is small, its presence can make a person feel uncomfortab...
Detailed Description
Topical medications are the primary option for addressing RAS (Recurrent Aphthous Stomatitis) due to their affordability, effectiveness, and safety. These treatments encompass various forms such as mo...
Eligibility Criteria
Inclusion
- Age 18-59years
- Healthy subjects without mouth diseases
- Not using drugs for RAS therapy
- Not involved with other clinical trials
- Willing to participate
Exclusion
- Have a mouth disease
- Have other serious illnesses, including arrhythmia, uncontrolled hypertension, diabetes, hepatitis, and kidney failure
- pregnant or lactating women, and women who wish to become pregnant during the study period
- poor oral hygiene that requires treatment
- chronic diseases requiring treatment with antibiotics, hormones, nonsteroidal anti-inflammatory drugs, immunosuppressants, immune enhancers, cytotoxic drugs, or cell cycle agents that affect the oral mucosa
- mental illness or limited mental capacities
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06039774
Start Date
December 4 2023
End Date
December 20 2024
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Padjadjaran University Dental and Oral Hospital
Bandung, West Java, Indonesia, 40132